Therapeutic Drug Monitoring of Voriconazole

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether therapeutic drug monitoring of voriconazole is useful in the treatment of invasive fungal infection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Voriconazole

Criteria

Inclusion Criteria:

• patients who were 16 years of age or older

• receiving voriconazole in order to treat invasive fungal infections or for empirical use

Exclusion Criteria:

• who experienced the serious side effect of voriconazole

• were hypersensitive to azoles

• had an aminotransferase, bilirubin, or alkaline phosphatase level higher than five times the upper limit of normal